EBV-POSITIVE NASOPHARYNGEAL CARCINOMA

Clinical trials for EBV-POSITIVE NASOPHARYNGEAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new EBV-POSITIVE NASOPHARYNGEAL CARCINOMA trials appear

Sign up with your email to follow new studies for EBV-POSITIVE NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Supercharged immune cells take aim at Virus-Linked cancer

Disease control Ongoing

This early-stage study is testing a new type of cell therapy for patients with EBV-positive nasopharyngeal cancer that has returned or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cancer cells…

Matched conditions: EBV-POSITIVE NASOPHARYNGEAL CARCINOMA

Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

EBV-POSITIVE NASOPHARYNGEAL CARCINOMA

Get alerted when new EBV-POSITIVE NASOPHARYNGEAL CARCINOMA trials appear

Supercharged immune cells take aim at Virus-Linked cancer